495 related articles for article (PubMed ID: 29067871)
41. High IgA antiphospholipid autoantibodies in healthy Sudanese explain the increased prevalence among Sudanese compared to Swedish systemic lupus erythematosus patients.
Elbagir S; Elshafie AI; Elagib EM; Mohammed NA; Aledrissy MI; Manivel VA; Pertsinidou E; Nur MA; Gunnarsson I; Svenungsson E; Rönnelid J
Lupus; 2020 Oct; 29(11):1412-1422. PubMed ID: 32741301
[TBL] [Abstract][Full Text] [Related]
42. Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events.
Otomo K; Atsumi T; Amengual O; Fujieda Y; Kato M; Oku K; Horita T; Yasuda S; Koike T
Arthritis Rheum; 2012 Feb; 64(2):504-12. PubMed ID: 21953404
[TBL] [Abstract][Full Text] [Related]
43. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
Danowski A; Kickler TS; Petri M
J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
[TBL] [Abstract][Full Text] [Related]
44. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
45. Antiphospholipid Syndrome With Isolated Isotype M Anticardiolipin and/or Anti-B2GPI Antibody Is Associated With Stroke.
Urbanski G; Yelnik CM; Maillard H; Launay D; Dubucquoi S; Hachulla E; Hatron PY; Lambert M
Stroke; 2018 Nov; 49(11):2770-2772. PubMed ID: 30355196
[TBL] [Abstract][Full Text] [Related]
46. Autoantibody explosion in antiphospholipid syndrome.
Shoenfeld Y; Twig G; Katz U; Sherer Y
J Autoimmun; 2008; 30(1-2):74-83. PubMed ID: 18171610
[TBL] [Abstract][Full Text] [Related]
47. Contribution of anti-β2glycoprotein I IgA antibodies to the diagnosis of anti-phospholipid syndrome: potential interest of target domains to discriminate thrombotic and non-thrombotic patients.
Despierres L; Beziane A; Kaplanski G; Granel B; Serratrice J; Cohen W; Bretelle F; Rossi P; Morange PE; Weiller PJ; Robert Harlé J; Bongrand P; Bardin N
Rheumatology (Oxford); 2014 Jul; 53(7):1215-8. PubMed ID: 24599915
[TBL] [Abstract][Full Text] [Related]
48. Standardization of antiphospholipid antibody testing--historical perspectives and ongoing initiatives.
Willis R; Lakos G; Harris EN
Semin Thromb Hemost; 2014 Mar; 40(2):172-7. PubMed ID: 24470286
[TBL] [Abstract][Full Text] [Related]
49. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
50. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β
Elbagir S; Mohammed NA; Kaihola H; Svenungsson E; Gunnarsson I; Manivel VA; Pertsinidou E; Elagib EM; Nur MAM; Elussein EA; Elshafie A; Åkerud H; Rönnelid J
Lupus; 2020 Apr; 29(5):463-473. PubMed ID: 32106789
[TBL] [Abstract][Full Text] [Related]
51. Antiphospholipid syndrome - an update.
Linnemann B
Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
[TBL] [Abstract][Full Text] [Related]
52. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
de Laat B; Mertens K; de Groot PG
Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
[TBL] [Abstract][Full Text] [Related]
53. IgA antiphospholipid antibodies are an independent risk factor for thromboses.
Shen YM; Lee R; Frenkel E; Sarode R
Lupus; 2008 Nov; 17(11):996-1003. PubMed ID: 18852223
[TBL] [Abstract][Full Text] [Related]
54. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
Demir S; Li J; Magder LS; Petri M
Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
[TBL] [Abstract][Full Text] [Related]
55. Risk assessment in patients with antiphospholipid antibodies.
Bertero M; Kuzenko A
Minerva Med; 2013 Dec; 104(6):639-48. PubMed ID: 24316917
[TBL] [Abstract][Full Text] [Related]
56. Antiphospholipid antibodies: evaluation of the thrombotic risk.
Devreese KM
Thromb Res; 2012 Oct; 130 Suppl 1():S37-40. PubMed ID: 23026657
[TBL] [Abstract][Full Text] [Related]
57. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
58. Novel assays of thrombogenic pathogenicity in the antiphospholipid syndrome based on the detection of molecular oxidative modification of the major autoantigen β2-glycoprotein I.
Ioannou Y; Zhang JY; Qi M; Gao L; Qi JC; Yu DM; Lau H; Sturgess AD; Vlachoyiannopoulos PG; Moutsopoulos HM; Rahman A; Pericleous C; Atsumi T; Koike T; Heritier S; Giannakopoulos B; Krilis SA
Arthritis Rheum; 2011 Sep; 63(9):2774-82. PubMed ID: 21618459
[TBL] [Abstract][Full Text] [Related]
59. The emerging role of multiple antiphospholipid antibodies positivity in patients with antiphospholipid syndrome.
Forastiero R; Martinuzzo M
Expert Rev Clin Immunol; 2015; 11(11):1255-63. PubMed ID: 26295486
[TBL] [Abstract][Full Text] [Related]
60. Clinical performance of antibodies to prothrombin and thrombin in Chinese patients with antiphospholipid syndrome: potential interest in discriminating patients with thrombotic events and non-thrombotic events.
Zhang S; Wu Z; Li J; Li P; Chen S; Wen X; Li L; Zhang W; Zhao J; Zhang F; Li Y
Rheumatol Int; 2017 Apr; 37(4):579-584. PubMed ID: 27807637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]